Considering that there is a synergistic antitumor effect between DSF/Cu and PLX4032 in BRAFV600E-mutated thyroid cancer cells, we thus speculated that DSF/Cu may improve cellular response to PLX4032 by relieving feedback activation of HER3 signaling and its downstream pathways. The gene discussed is ERBB3; the disease is thyroid cancer.